Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $5,787 | 383 | 100.0% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Novo Nordisk Inc | $832.72 | 70 | $0 (2024) |
| PFIZER INC. | $628.04 | 34 | $0 (2024) |
| Lilly USA, LLC | $504.95 | 44 | $0 (2024) |
| AstraZeneca Pharmaceuticals LP | $432.68 | 29 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $420.84 | 28 | $0 (2024) |
| ABBVIE INC. | $416.01 | 25 | $0 (2024) |
| Amgen Inc. | $374.10 | 23 | $0 (2024) |
| GlaxoSmithKline, LLC. | $362.25 | 20 | $0 (2024) |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $362.03 | 21 | $0 (2024) |
| Astellas Pharma US Inc | $346.31 | 19 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,405 | 90 | PFIZER INC. ($310.48) |
| 2023 | $1,191 | 78 | Otsuka America Pharmaceutical, Inc. ($174.63) |
| 2022 | $918.24 | 62 | Otsuka America Pharmaceutical, Inc. ($137.28) |
| 2021 | $874.52 | 52 | AbbVie Inc. ($133.31) |
| 2020 | $555.02 | 43 | Novo Nordisk Inc ($204.91) |
| 2019 | $758.94 | 51 | Boehringer Ingelheim Pharmaceuticals, Inc. ($145.89) |
| 2018 | $84.41 | 7 | AstraZeneca Pharmaceuticals LP ($70.42) |
All Payment Transactions
383 individual payment records from CMS Open Payments — Page 1 of 16
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $24.98 | General |
| Category: VACCINES | ||||||
| 12/18/2024 | PFIZER INC. | PAXLOVID (Drug) | Food and Beverage | In-kind items and services | $13.98 | General |
| Category: INFECTIOUS DISEASES | ||||||
| 12/13/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $6.05 | General |
| Category: Hepatitis B Vaccine | ||||||
| 12/12/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.24 | General |
| Category: PAIN | ||||||
| 11/21/2024 | AstraZeneca Pharmaceuticals LP | BREZTRI (Drug) | Food and Beverage | In-kind items and services | $15.85 | General |
| Category: Respiratory | ||||||
| 11/20/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $18.29 | General |
| Category: Diabetes | ||||||
| 11/13/2024 | ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) | CAPLYTA (Drug) | Food and Beverage | In-kind items and services | $14.66 | General |
| Category: PSYCHIATRY | ||||||
| 11/06/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $15.29 | General |
| Category: PSYCHIATRY | ||||||
| 10/30/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $12.64 | General |
| Category: NEUROSCIENCE | ||||||
| 10/27/2024 | GlaxoSmithKline, LLC. | SHINGRIX (Biological) | Food and Beverage | In-kind items and services | $24.14 | General |
| Category: VACCINES | ||||||
| 10/24/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.20 | General |
| Category: PAIN | ||||||
| 10/21/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Biological | ||||||
| 10/18/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $6.49 | General |
| Category: Diabetes | ||||||
| 10/10/2024 | Lilly USA, LLC | MOUNJARO (Drug) | Food and Beverage | In-kind items and services | $12.94 | General |
| Category: Diabetes | ||||||
| 10/09/2024 | Novo Nordisk Inc | Ozempic (Drug), Rybelsus | Food and Beverage | In-kind items and services | $17.17 | General |
| Category: Diabetes | ||||||
| 10/03/2024 | PFIZER INC. | ELIQUIS (Drug), NURTEC ODT | Food and Beverage | In-kind items and services | $23.22 | General |
| Category: CARDIOVASCULAR;METABOLIC DISEASE | ||||||
| 09/26/2024 | GlaxoSmithKline, LLC. | TRELEGY ELLIPTA (Drug), AREXVY | Food and Beverage | In-kind items and services | $29.38 | General |
| Category: RESPIRATORY | ||||||
| 09/26/2024 | AstraZeneca Pharmaceuticals LP | AIRSUPRA (Drug) | Food and Beverage | In-kind items and services | $14.50 | General |
| Category: Respiratory | ||||||
| 09/23/2024 | Astellas Pharma US Inc | Veozah (Drug) | Food and Beverage | In-kind items and services | $18.79 | General |
| Category: Biological | ||||||
| 09/19/2024 | PFIZER INC. | NURTEC ODT (Drug), ZAVZPRET | Food and Beverage | In-kind items and services | $26.54 | General |
| Category: PAIN | ||||||
| 09/12/2024 | Otsuka America Pharmaceutical, Inc. | REXULTI (Drug) | Food and Beverage | In-kind items and services | $28.05 | General |
| Category: PSYCHIATRY | ||||||
| 09/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $6.76 | General |
| Category: VACCINES | ||||||
| 09/11/2024 | PFIZER INC. | PREVNAR 20 (Biological), COMIRNATY, ABRYSVO | Food and Beverage | In-kind items and services | $4.26 | General |
| Category: VACCINES | ||||||
| 09/09/2024 | Lilly USA, LLC | ZEPBOUND (Drug) | Food and Beverage | In-kind items and services | $11.46 | General |
| Category: Obesity | ||||||
| 09/04/2024 | Dynavax Technologies Corporation | Heplisav-B (Drug) | Food and Beverage | In-kind items and services | $20.92 | General |
| Category: Hepatitis B Vaccine | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 30 | 1,719 | 2,690 | $180,451 | $72,926 |
| 2022 | 29 | 1,914 | 2,952 | $192,028 | $80,626 |
| 2021 | 33 | 2,150 | 2,943 | $200,083 | $88,870 |
| 2020 | 37 | 2,182 | 2,952 | $197,393 | $80,266 |
All Medicare Procedures & Services
129 procedure records from CMS Medicare Utilization — Page 1 of 6
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 139 | 312 | $64,140 | $25,155 | 39.2% |
| G0439 | Annual wellness visit, includes a personalized prevention plan of service (pps), subsequent visit | Office | 2023 | 107 | 107 | $17,655 | $13,060 | 74.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 78 | 98 | $12,900 | $5,202 | 40.3% |
| 80061 | Blood test, lipids (cholesterol and triglycerides) | Office | 2023 | 140 | 238 | $10,710 | $3,088 | 28.8% |
| 36415 | Insertion of needle into vein for collection of blood sample | Office | 2023 | 148 | 366 | $3,660 | $3,052 | 83.4% |
| 80053 | Blood test, comprehensive group of blood chemicals | Office | 2023 | 146 | 291 | $9,603 | $2,984 | 31.1% |
| 84443 | Blood test, thyroid stimulating hormone (tsh) | Office | 2023 | 123 | 168 | $8,904 | $2,751 | 30.9% |
| 99497 | Advance care planning, first 30 minutes | Office | 2023 | 28 | 28 | $4,284 | $2,184 | 51.0% |
| 82306 | Vitamin d-3 level | Office | 2023 | 47 | 65 | $6,175 | $1,837 | 29.7% |
| 90694 | Influenza vaccine, quadrivalent inactivated, 0.5 ml dosage | Office | 2023 | 24 | 24 | $2,448 | $1,814 | 74.1% |
| 85025 | Complete blood cell count (red cells, white blood cell, platelets), automated test and automated differential white blood cell count | Office | 2023 | 142 | 216 | $6,480 | $1,637 | 25.3% |
| G0446 | Annual, face-to-face intensive behavioral therapy for cardiovascular disease, individual, 15 minutes | Office | 2023 | 57 | 57 | $2,850 | $1,397 | 49.0% |
| 83036 | Hemoglobin a1c level | Office | 2023 | 71 | 126 | $4,410 | $1,167 | 26.5% |
| G0444 | Annual depression screening, 5 to 15 minutes | Office | 2023 | 54 | 54 | $1,890 | $930.42 | 49.2% |
| G0008 | Administration of influenza virus vaccine | Office | 2023 | 27 | 27 | $972.00 | $767.88 | 79.0% |
| 84439 | Thyroxine (thyroid chemical), free | Office | 2023 | 48 | 82 | $5,740 | $709.94 | 12.4% |
| 77080 | Dxa bone density measurement of hip, pelvis, spine | Office | 2023 | 18 | 18 | $2,700 | $631.80 | 23.4% |
| G0103 | Prostate cancer screening; prostate specific antigen test (psa) | Office | 2023 | 34 | 34 | $1,700 | $625.26 | 36.8% |
| 87426 | Detection test by immunoassay technique for severe acute respiratory syndrome coronavirus | Office | 2023 | 16 | 18 | $1,170 | $623.16 | 53.3% |
| 84153 | Psa (prostate specific antigen) measurement, total | Office | 2023 | 20 | 28 | $1,400 | $504.56 | 36.0% |
| 82728 | Ferritin (blood protein) level | Office | 2023 | 27 | 34 | $1,428 | $454.24 | 31.8% |
| 82607 | Cyanocobalamin (vitamin b-12) level | Office | 2023 | 23 | 29 | $1,363 | $428.62 | 31.4% |
| 80048 | Blood test, basic group of blood chemicals (calcium, total) | Office | 2023 | 35 | 50 | $1,500 | $407.26 | 27.2% |
| 82043 | Urine microalbumin (protein) level | Office | 2023 | 39 | 58 | $1,740 | $323.40 | 18.6% |
| G0447 | Face-to-face behavioral counseling for obesity, 15 minutes | Office | 2023 | 12 | 12 | $540.00 | $290.40 | 53.8% |
About Dr. Brian Gray, D.O
Dr. Brian Gray, D.O is a Family Medicine healthcare provider based in Murfreesboro, Tennessee. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/28/2015. The National Provider Identifier (NPI) number assigned to this provider is 1003293028.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Brian Gray, D.O has received a total of $5,787 in payments from pharmaceutical and medical device companies, with $1,405 received in 2024. These payments were reported across 383 transactions from 33 companies. The most common payment nature is "Food and Beverage" ($5,787).
As a Medicare-enrolled provider, Gray has provided services to 7,965 Medicare beneficiaries, totaling 11,537 services with total Medicare billing of $322,687. Data is available for 4 years (2020–2023), covering 129 distinct procedure/service records.
Practice Information
- Specialty Family Medicine
- Location Murfreesboro, TN
- Active Since 04/28/2015
- Last Updated 06/25/2020
- Taxonomy Code 207Q00000X
- Entity Type Individual
- NPI Number 1003293028
Products in Payments
- Ozempic (Drug) $490.02
- JARDIANCE (Drug) $421.36
- REXULTI (Drug) $420.84
- NURTEC ODT (Drug) $318.39
- UBRELVY (Drug) $258.58
- MOUNJARO (Drug) $232.73
- EVENITY (Biological) $226.48
- SHINGRIX (Biological) $220.42
- FARXIGA (Drug) $215.47
- TRINTELLIX (Drug) $169.98
- Veozah (Drug) $159.05
- MYRBETRIQ (Drug) $130.49
- ZEPBOUND (Drug) $127.03
- Rybelsus (Drug) $117.55
- PREVNAR 20 (Biological) $117.33
- TRELEGY ELLIPTA (Drug) $111.02
- BELSOMRA (Drug) $100.07
- VRAYLAR (Drug) $93.88
- Aimovig (Biological) $86.35
- SYMBICORT (Drug) $84.31
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Family Medicine Doctors in Murfreesboro
Dr. Scott Eller, M.d, M.D
Family Medicine — Payments: $18,623
Dr. Thomas Helton, Md, MD
Family Medicine — Payments: $15,111
Dr. Laura Born, Md, MD
Family Medicine — Payments: $13,627
Dr. Adam Childs, M.d, M.D
Family Medicine — Payments: $13,253
Dennis Carter, Md, MD
Family Medicine — Payments: $11,679
Nicholas Cote, D.o, D.O
Family Medicine — Payments: $10,359